Navtemadlin and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Meng X Welliver
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
53 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ctca at Western Regional Medical Center
Goodyear, Arizona, United States
- Mayo Clinic Hospital in Arizona
Phoenix, Arizona, United States
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- University of Arizona Cancer Center-North Campus
Tucson, Arizona, United States
- University of Arizona Cancer Center-Orange Grove Campus
Tucson, Arizona, United States
- Uchealth University of Colorado Hospital
Aurora, Colorado, United States
- Poudre Valley Hospital
Fort Collins, Colorado, United States
- Emory University Hospital Midtown
Atlanta, Georgia, United States
- Emory University Hospital/winship Cancer Institute
Atlanta, Georgia, United States
- Northside Hospital
Atlanta, Georgia, United States
- Ctca at Southeastern Regional Medical Center
Newnan, Georgia, United States
- Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho, United States
- Northwestern University
Chicago, Illinois, United States
- Rush University Medical Center
Chicago, Illinois, United States
- University of Kansas Cancer Center-Overland Park
Overland Park, Kansas, United States
- the James Graham Brown Cancer Center at University of Louisville
Louisville, Kentucky, United States
- Mayo Clinic in Rochester
Rochester, Minnesota, United States
- Siteman Cancer Center at West County Hospital
Creve Coeur, Missouri, United States
- Siteman Cancer Center-South County
St Louis, Missouri, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Benefis Sletten Cancer Institute
Great Falls, Montana, United States
- Logan Health Medical Center
Kalispell, Montana, United States
- Nebraska Methodist Hospital
Omaha, Nebraska, United States
- Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Nyp/columbia University Medical Center/herbert Irving Comprehensive Cancer Center
New York, New York, United States
- Unc Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
- Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
- University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
- Eastern Regional Medical Center
Philadelphia, Pennsylvania, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
- Upmc-Shadyside Hospital
Pittsburgh, Pennsylvania, United States
- Parkland Memorial Hospital
Dallas, Texas, United States
- Ut Southwestern/simmons Cancer Center-Dallas
Dallas, Texas, United States
- Aurora Cancer Care-Southern Lakes Vlcc
Burlington, Wisconsin, United States
- Aurora Health Center-Fond Du Lac
Fond du Lac, Wisconsin, United States
- Aurora Health Care Germantown Health Center
Germantown, Wisconsin, United States
- Aurora Cancer Care-Grafton
Grafton, Wisconsin, United States
- Aurora Baycare Medical Center
Green Bay, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Jun 2018
- Primary completion
- 27 Aug 2023
- Completion
- 4 Sept 2025
- Last update posted
- 23 Sept 2025
- Registered enrollment
- 39
- Registry id
- NCT03217266
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.